(Q81241494)
Statements
The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders (English)
C Bellanné-Chantelot
P Jego
P Lionne-Huyghe
M Tulliez
A Najman
French group on myeloproliferative disorders
13 September 2007